SyntheZyme

company

About

SyntheZyme a privately held sustainable chemical company commercializing the technology developed in the laboratories.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$149.99K
Industries
Bioinformatics,Biotechnology,Chemical,Manufacturing
Founded date
Jan 1, 2008
Number Of Employee
1 - 10
Operating Status
Active

SyntheZyme is a privately held sustainable chemical company commercializing the technology developed in the laboratories of Professor Richard A. Gross.

Dr. Gross is a Constellation Chair of Biocatalysis and Metabolic Engineering in RPI’s Center for Interdisciplinary Science.

Located in Rensselaer, NY. SyntheZyme uses the understanding of biocatalysis to replace petrochemical based industrial chemicals with biobased and biodegradable alternatives. Focusing on chemicals for plastics, pesticides, cosmetics and personal care product ingredients. Nature’s chemistry shows the way and provides the tools that are used by SyntheZyme.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$149.99K
SyntheZyme has raised a total of $149.99K in funding over 2 rounds. Their latest funding was raised on Dec 11, 2012 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 11, 2012 Grant $149.99K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
SyntheZyme is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant